Natco Pharma fell 1.76% to Rs 850.60 after consolidated net profit dropped 14.49% to Rs 122.10 crore on 14.44% jump in net sales to Rs 563.40 crore in Q1 June 2020 over Q1 June 2019.
Profit before tax (PBT) declined 13.98% to Rs 158.10 crore in Q1 June 2020 as against Rs 183.80 crore in Q1 June 2019. Current tax expense for the quarter rose 3.65% to Rs 42.5 crore as against Rs 41 crore in Q1 June 2019. The Q1 result was declared during trading hours today, 12 August 2020.
Increase in revenue was driven primarily by exports formulations business. During the quarter, the company faced margins pressure on both domestic and international formulations. In spite of lower margins during the first quarter, the company is confident of its business for remaining part of the financial year based on the order book and earnings outlook. The company expects a growth of over 25% in its earnings for FY2020-21 compared to prior year.
The board has recommended an interim dividend of Rs 1.25 per equity share of Rs 2 each, during Q1 FY21.
Natco Pharma is among fastest growing pharmaceutical companies in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app